TG Therapeutics, Inc. TGTX
60.75 USD +0.80 (+1.33%)
At closeNov 3, 2026, 6:09 PM EST
60.99 +0.24 +0.40%
After hours · Nov 3, 6:09 PM ET
60.02 Day range 62.20
26.76 52-week range 63.60
- YTD
- +103.79%
- 1 year
- +80.32%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 69.71 +14.8% upside
Now 60.75
- Target (low)
- 21.00
- Target (mean)
- 69.71
- Target (high)
- 86.00
Ratings (0m) 8 7 buy · 0 hold · 1 sell
- Strong buy1
- Buy6
- Hold0
- Sell0
- Strong sell1
Recommendation trend
- This month 8
- 1 month ago 8
- 2 months ago 8
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.2575 | 0.19 – 0.35 | 0.1609 | +60.0% | 245.45M | +51.8% | 4 |
| Next quarter | 0.40667 | 0.33 – 0.45 | 0.14 | +190.5% | 269.46M | +39.9% | 3 |
| Current year | 0.95 | 0.70 – 1.32 | 2.77 | -65.7% | 960.26M | +55.8% | 4 |
| Next year | 2.71 | 2.16 – 3.96 | 0.95 | +185.1% | 1.32B | +37.4% | 5 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 1, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 7, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Jul 27, 2026 | B. Riley Securities | Maintained | Buy | Buy |
| Jul 13, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Jul 7, 2026 | B of A Securities | Maintained | Underperform | Underperform |
| Jul 6, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 27, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 6, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Feb 2, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Jan 15, 2026 | Goldman Sachs | Maintained | Neutral | Neutral |
| Nov 3, 2025 | JP Morgan | Maintained | Overweight | Overweight |
| Sep 17, 2025 | B. Riley Securities | Maintained | Buy | Buy |
| Mar 4, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jan 15, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 25, 2024 | JP Morgan | Maintained | Overweight | Overweight |
| Nov 5, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Nov 5, 2024 | Goldman Sachs | Maintained | Neutral | Neutral |
| Oct 29, 2024 | TD Cowen | Initiated | — | Buy |
| Sep 18, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 7, 2024 | B. Riley Securities | Maintained | Buy | Buy |
| Aug 7, 2024 | Goldman Sachs | Maintained | Neutral | Neutral |
| Aug 6, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 2, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| May 2, 2024 | Ladenburg Thalmann | Maintained | Buy | Buy |
| Apr 18, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Apr 18, 2024 | JP Morgan | Reiterated | Overweight | Overweight |
| Apr 18, 2024 | Ladenburg Thalmann | Reiterated | Buy | Buy |
| Mar 1, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Feb 29, 2024 | Goldman Sachs | Maintained | Neutral | Neutral |
| Feb 28, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |